1 – 5 of 28
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma : results from a Nordic Lymphoma Group phase II trial
(
- Contribution to journal › Letter
-
Mark
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
(
- Contribution to journal › Article
- 2020
-
Mark
SN 2019ehk: A Double-Peaked Ca-rich Transient with Luminous X-ray Emission and Shock-Ionized Spectral Features
(
- Contribution to journal › Article
- 2019
-
Mark
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
(
- Contribution to journal › Article
-
Mark
Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases
(
- Contribution to journal › Article